SCHEMBL17853232

SCHEMBL17853232

CC1(C)c2cc(-c3ccc(-c4ccccc4)cc3)ccc2-c2ccc(N(c3cccc(-c4ccc5oc6ccccc6c5c4)c3)c3ccccc3-c3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.34
PLA2G4A P47712 4/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PLA2G10 O15496 1/20 0.33
ALK Q9UM73 1/20 0.33
PDK2 Q15119 1/20 0.31
PRKDC P78527 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
PGR P06401 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17733223 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17853200 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17853225 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17733377 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17733493 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17733514 0.95 ALK (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17853223 0.95 ALK (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17733351 0.95 ALK (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17853247 0.94 PGR (0.32) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL17853256 0.94 CA12 (0.33) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10411192-B2 Aromatic amine compound, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-09-10 US disclosed
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10411192-B2 Aromatic amine compound, organic electroluminescent element and electronic device AOC2, PNMT, TYR PLA2G2A 4251/4885PLA2G4A 4697/4885HSP90AA1 4745/4885
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE AOC2, PNMT, TYR PLA2G2A 4251/4885PLA2G4A 4697/4885HSP90AA1 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.